STRIDES PHARMA SCIENCE LIMITED — Capital/Financing Update 2024

Dec 11, 2024

==> picture [153 x 50] intentionally omitted <==

December 11, 2024

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051

Scrip code: STAR

Dear Madam/ Sirs,

• Ref: Scheme of Arrangement amongst Strides Pharma Science Limited (Strides), Steriscience Specialties Private Limited (Steriscience) and OneSource Specialty Pharma Limited (OneSource) and their respective shareholders (‘Scheme’) pursuant to Section 230-232 of the Companies Act, 2013 and Rules framed thereunder.

Sub: Allotment of Equity Shares by OneSource pursuant to the Scheme

With reference to the above, OneSource has informed the Company that they have completed allotment of Equity Shares on December 10, 2024, to Shareholders of the Company who are holding Strides’ Equity Shares as on the Record Date i.e., Friday, December 6, 2024.

In line with the Share Entitlement Ratio, OneSource has allotted One Equity Share of Re. 1/- each of OneSource for every Two Equity Shares of Rs. 10/- held by Strides’ shareholders.

Next Steps by OneSource

• Allotment Confirmation - OneSource shall proceed with crediting the equity shares to respective shareholders’ demat account and shall provide allotment confirmation to respective shareholders in due course.

• Allotment of shares in demat mode: As per the provisions of SEBI Regulations, allotment of shares shall be made only in demat form.

Accordingly, OneSource shall consolidate share entitlement of physical shareholders of Strides as unclaimed shares and credit them to a designated account titled “OneSource – Unclaimed Securities – Suspense Escrow Account”.

These shares shall be transferred to respective shareholders, once such shareholders demat their Strides shares, and provide requisite information relating to their demat account to OneSource/ Integrated Registry Management Services Private Limited (RTA of OneSource).

• Fractional Entitlement , if any, shall be consolidated and held in trust by “Catalyst Trusteeship Limited” on behalf of shareholders entitled to such fractional entitlements.

Catalyst shall hold such shares in trust for the specific purpose of selling the same in the market at any time within 90 days from the date of allotment by OneSource.

Upon completion of such sale, net sale proceeds shall be distributed (after deduction of expenses incurred and applicable income tax) to the respective shareholders eligible for fractional entitlements.

==> picture [500 x 48] intentionally omitted <==

==> picture [153 x 50] intentionally omitted <==

• Listing of OneSource Shares: OneSource is in the process of filing Information Memorandum with the Stock Exchanges during December 2024 and is expecting to receive Listing Approval from the Stock Exchanges during Q4 FY 25.

Until such period shares allotted pursuant to the Scheme shall remain frozen in the Depositories system. Upon receipt of Listing Approval, shares of OneSource shall be available for trading on the Stock Exchanges.

A separate communication relating to Cost of Acquisition of Strides and OneSource Shares (pursuant to demerger) shall be shared by the Company in due course.

You are kindly requested to take the same on record.

Thanks & Regards, For Strides Pharma Science Limited, Digitally signed by MANJULA R MANJULA R Date: 2024.12.11 19:13:11 +05'30'

Manjula Ramamurthy Company Secretary ICSI Membership No. A30515

==> picture [500 x 48] intentionally omitted <==